While no officially approved human dosing exists, community experience and extrapolation from animal research provide useful guidance
More clinical evaluations are needed to firmly establish the role of DSIP in human sleep and central nervous system disorders
What the Research Shows BPC-157 is a synthetic 15-amino-acid peptide with over 100 preclinical studies
Individuals with certain medical conditions or health concerns, such as kidney disease, liver disease, certain blood disorders, or allergies to specific vitamins, may need to avoid or modify the therapy
The practical takeaway: AOD-9604 has a clean safety profile in trials but a failed Phase 2b efficacy endpoint
The follow results were observed after 8-weeks of treatment: [table id=360 /] The score was significantly lower in the methyl B 12 group (0.7 greater improvement in methyl B 12 group